Flputnam Investment Management CO Charles River Laboratories International, Inc. Transaction History

Flputnam Investment Management CO

  • $5.35 Billion
  • Q4 2024

A detailed history of Flputnam Investment Management CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Flputnam Investment Management CO holds 1,962 shares of CRL stock, worth $295,320. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,962
Previous 3,939 50.19%
Holding current value
$295,320
Previous $775,000 53.29%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
SELL
$178.58 - $220.69 $353,052 - $436,304
-1,977 Reduced 50.19%
1,962 $362,000
Q3 2024

Nov 08, 2024
SELL
$187.96 - $245.29 $6.76 Million - $8.83 Million
-35,986 Reduced 90.13%
3,939 $775,000
Q2 2024

Aug 14, 2024
SELL
$206.39 - $268.73 $4.6 Million - $5.99 Million
-22,286 Reduced 35.82%
39,925 $8.25 Million
Q1 2024

May 03, 2024
BUY
$203.52 - $273.43 $90,159 - $121,129
443 Added 0.72%
62,211 $16.9 Million
Q4 2023

Jan 30, 2024
BUY
$164.52 - $238.84 $706,284 - $1.03 Million
4,293 Added 7.47%
61,768 $14.6 Million
Q3 2023

Nov 06, 2023
SELL
$194.44 - $217.61 $22,166 - $24,807
-114 Reduced 0.2%
57,475 $11.3 Million
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $323,697 - $370,460
-1,762 Reduced 2.97%
57,589 $12.1 Million
Q1 2023

Apr 27, 2023
SELL
$191.89 - $259.92 $58,334 - $79,015
-304 Reduced 0.51%
59,351 $12 Million
Q4 2022

Jan 31, 2023
BUY
$197.11 - $250.07 $613,800 - $778,717
3,114 Added 5.51%
59,655 $13 Million
Q3 2022

Nov 07, 2022
SELL
$182.44 - $250.54 $120,045 - $164,855
-658 Reduced 1.15%
56,541 $11.1 Million
Q2 2022

Aug 08, 2022
BUY
$204.13 - $302.4 $162,283 - $240,407
795 Added 1.41%
57,199 $12.2 Million
Q1 2022

Apr 28, 2022
SELL
$255.51 - $362.11 $3.26 Million - $4.62 Million
-12,749 Reduced 18.44%
56,404 $16 Million
Q4 2021

Feb 15, 2022
SELL
$351.38 - $448.68 $6.88 Million - $8.78 Million
-19,573 Reduced 22.06%
69,153 $26.1 Million
Q3 2021

Oct 26, 2021
SELL
$372.64 - $458.3 $227,683 - $280,021
-611 Reduced 0.68%
88,726 $36.6 Million
Q2 2021

Aug 11, 2021
SELL
$294.17 - $371.65 $2.42 Million - $3.06 Million
-8,242 Reduced 8.45%
89,337 $33 Million
Q1 2021

May 14, 2021
SELL
$249.67 - $299.48 $641,651 - $769,663
-2,570 Reduced 2.57%
97,579 $28.3 Million
Q4 2020

Feb 02, 2021
BUY
$222.0 - $252.62 $3.86 Million - $4.39 Million
17,384 Added 21.0%
100,149 $25 Million
Q3 2020

Nov 03, 2020
SELL
$175.56 - $226.45 $743,145 - $958,562
-4,233 Reduced 4.87%
82,765 $18.7 Million
Q2 2020

Aug 13, 2020
SELL
$118.84 - $189.72 $445,650 - $711,450
-3,750 Reduced 4.13%
86,998 $15.2 Million
Q1 2020

May 08, 2020
BUY
$98.9 - $178.34 $290,864 - $524,497
2,941 Added 3.35%
90,748 $11.5 Million
Q4 2019

Jan 30, 2020
SELL
$126.05 - $152.76 $78,024 - $94,558
-619 Reduced 0.7%
87,807 $13.4 Million
Q3 2019

Nov 05, 2019
SELL
$125.07 - $143.67 $165,842 - $190,506
-1,326 Reduced 1.48%
88,426 $11.7 Million
Q2 2019

Jul 25, 2019
BUY
$123.4 - $148.55 $26,284 - $31,641
213 Added 0.24%
89,752 $12.7 Million
Q1 2019

May 15, 2019
SELL
$104.82 - $146.73 $41,928 - $58,691
-400 Reduced 0.44%
89,539 $13 Million
Q4 2018

Feb 22, 2019
BUY
$105.09 - $137.23 $109,503 - $142,993
1,042 Added 1.17%
89,939 $10.2 Million
Q3 2018

Nov 13, 2018
BUY
$112.11 - $134.54 $52,019 - $62,426
464 Added 0.52%
88,897 $12 Million
Q2 2018

Aug 01, 2018
BUY
$102.37 - $117.25 $13,000 - $14,890
127 Added 0.14%
88,433 $9.93 Million
Q1 2018

May 01, 2018
SELL
$98.19 - $115.2 $1.89 Million - $2.21 Million
-19,219 Reduced 17.87%
88,306 $9.43 Million
Q4 2017

Feb 06, 2018
SELL
$100.43 - $118.09 $1.46 Million - $1.71 Million
-14,499 Reduced 11.88%
107,525 $11.8 Million
Q3 2017

Nov 07, 2017
BUY
$96.72 - $109.26 $11.8 Million - $13.3 Million
122,024
122,024 $13.2 Million

Others Institutions Holding CRL

# of Institutions
710
Shares Held
50M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.66B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email